Insiders Updates RLAY stock rated an Equal weight by Wells Fargo Relay Therapeutics Inc’s filing revealed that its insider Rahmer Peter unloaded Company’s shares for reported $32217.0 on Apr 30 ’25.
Analysts Viewpoint Analysts: RLAY stock price target of 19 in 12 months Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Relay Therapeutics